The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
High molecular weight, low molecular weight and very low molecular weight fibrinogen were purified from human plasma, and converted partially or completely to fibrin by the action of thrombin or batroxobin. The stimulatory effects of these fibrin(ogen) preparations on plasminogen activation by tissue plasminogen activator were studied. When only 3-30% of the fibrinogen molecules were converted to fibrin, the high molecular weight fibrin had a greater stimulatory effect on plasminogen activation than equal amounts of low and very low molecular weight fibrin. In completely converted fibrin preparations, the plasminogen activating capacity of high molecular weight fibrin was either equal to (thrombin treated preparations) or greater than (batroxobin-treated preparations) that of very low molecular weight fibrin. These findings suggest that degradation of the A alpha-chain of fibrin does not per se increase its plasminogen activating capacity.
Halvorsen
S
S
Department of Internal Medicine, Ullevaal Hospital, Oslo, Norway.
Skjønsberg
O H
OH
Godal
H C
HC
D012103:Batroxobin; D004789:Enzyme Activation / Q000187:drug effects*; D005337:Fibrin / Q000302:isolation & purification / Q000494:pharmacology*; D005338:Fibrin Fibrinogen Degradation Products / Q000494:pharmacology*; D005340:Fibrinogen / Q000737:chemistry* / Q000302:isolation & purification; D006801:Humans; D008970:Molecular Weight; D010958:Plasminogen; D013917:Thrombin; D010959:Tissue Plasminogen Activator
D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D012103:Batroxobin; D013917:Thrombin; D010959:Tissue Plasminogen Activator